These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 29881410)

  • 21. Chemistry and biology of multicomponent reactions.
    Dömling A; Wang W; Wang K
    Chem Rev; 2012 Jun; 112(6):3083-135. PubMed ID: 22435608
    [No Abstract]   [Full Text] [Related]  

  • 22. Multicomponent reaction design in the quest for molecular complexity and diversity.
    Ruijter E; Scheffelaar R; Orru RV
    Angew Chem Int Ed Engl; 2011 Jul; 50(28):6234-46. PubMed ID: 21710674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents.
    Fletcher S; Keaney EP; Cummings CG; Blaskovich MA; Hast MA; Glenn MP; Chang SY; Bucher CJ; Floyd RJ; Katt WP; Gelb MH; Van Voorhis WC; Beese LS; Sebti SM; Hamilton AD
    J Med Chem; 2010 Oct; 53(19):6867-88. PubMed ID: 20822181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
    Bandgar BP; Gawande SS; Bodade RG; Gawande NM; Khobragade CN
    Bioorg Med Chem; 2009 Dec; 17(24):8168-73. PubMed ID: 19896853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
    Hall A; Billinton A; Brown SH; Clayton NM; Chowdhury A; Giblin GM; Goldsmith P; Hayhow TG; Hurst DN; Kilford IR; Naylor A; Passingham B; Winyard L
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3392-9. PubMed ID: 18462938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal activity of a novel chromene dimer.
    Abrunhosa L; Costa M; Areias F; Venâncio A; Proença F
    J Ind Microbiol Biotechnol; 2007 Dec; 34(12):787-92. PubMed ID: 17899234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplasmodial activity of naphthoquinones related to lapachol and beta-lapachone.
    Pérez-Sacau E; Estévez-Braun A; Ravelo AG; Gutiérrez Yapu D; Giménez Turba A
    Chem Biodivers; 2005 Feb; 2(2):264-74. PubMed ID: 17191979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrazolopyranopyrimidines as a class of anti-inflammatory agents.
    Zaki ME; Soliman HA; Hiekal OA; Rashad AE
    Z Naturforsch C J Biosci; 2006; 61(1-2):1-5. PubMed ID: 16610208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally derived anti-HIV agents.
    Asres K; Seyoum A; Veeresham C; Bucar F; Gibbons S
    Phytother Res; 2005 Jul; 19(7):557-81. PubMed ID: 16161055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives.
    Sondhi SM; Singh N; Johar M; Kumar A
    Bioorg Med Chem; 2005 Nov; 13(22):6158-66. PubMed ID: 16115773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of beta-lapachone in pancreatic cancer treatment: exploiting the novel, therapeutic target NQO1.
    Ough M; Lewis A; Bey EA; Gao J; Ritchie JM; Bornmann W; Boothman DA; Oberley LW; Cullen JJ
    Cancer Biol Ther; 2005 Jan; 4(1):95-102. PubMed ID: 15662131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
    Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial activity of phenazines from lapachol, beta-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    de Andrade-Neto VF; Goulart MO; da Silva Filho JF; da Silva MJ; Pinto Mdo C; Pinto AV; Zalis MG; Carvalho LH; Krettli AU
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1145-9. PubMed ID: 14980653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient Synthesis and Antimicrobial Evaluation of Pyrazolopyranopyrimidines in the Presence of SBA-Pr-SO3H as a Nanoporous Acid Catalyst.
    Mohammadi Ziarani G; Aleali F; Lashgari N; Badiei A; Abolhasani Soorki A
    Iran J Pharm Res; 2018; 17(2):525-534. PubMed ID: 29881410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functionalized mesoporous SBA-15 silica: recent trends and catalytic applications.
    Verma P; Kuwahara Y; Mori K; Raja R; Yamashita H
    Nanoscale; 2020 Jun; 12(21):11333-11363. PubMed ID: 32285073
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.